MREO Mereo BioPharma Group plc
$0.29▲ +6.07%
Healthcare
Other
Volume 291.3K
Avg Volume (10D) 597.3K
Key Metrics & Fundamentals
Market Cap
$46.58M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.20 - 2.37
% vs 50 MA
-4.70%
% vs 200 MA
-13.85%
RSI-14
43.3
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.33
Free Cash Flow
-$6.04M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.33M
COGS
$0
Operating Exp
$6.91M
Operating Income
-$6.91M
EBIT
-$6.91M
Pretax Income
-$7.01M
Net Income
-$7.01M
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
GlobeNewswire · Aug 11, 2026 8:15 AM ET
Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
PR Newswire · Aug 11, 2026 8:00 AM ET
Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
GlobeNewswire · Aug 11, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2025
See MREO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.